Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2022

New developments in the management of recurrent/metastatic nasopharyngeal cancer

Recent advances in the development of 'liquid biopsy' in early detection and therapeutic monitoring of nasopharyngeal cancer

Date

12 Sep 2022

Session

New developments in the management of recurrent/metastatic nasopharyngeal cancer

Topics

Translational Research;  Secondary Prevention/Screening;  Cancer Diagnostics

Tumour Site

Head and Neck Cancers

Presenters

Wai Kei Jacky Lam

Authors

W.K.J. Lam

Author affiliations

  • Chemical Pathology Department, Prince of Wales Hospital, Sha Tin/HK

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Introduction and scientific background

Presenter: Brigette Ma

Session: New developments in the management of recurrent/metastatic nasopharyngeal cancer

Resources:

Slides

Webcast

Discussion

Presenter: All Speakers

Session: New developments in the management of recurrent/metastatic nasopharyngeal cancer

Resources:

Slides

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.